Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug or alcohol use disorder have entered any type of inpatient or outpatient ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...

From 2022 to 2023, there was a decrease in the age-adjusted rate of drug overdose death in the United States, according to a report published in the February Health E-Stats, a publication of the ...

After a meeting at the Mesilla Valley Public Housing Authority, Athena Huckaby saw a man across the street who had fallen out of a wheelchair yelling for help. She and a stranger got him back into his ...

A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...